Properties and clinical utility of topotecan fluorescence: uses for retinoblastoma.

Topotecan fluoresces when exposed to ultraviolet (UV) light. Our observations with UV light in retinoblastoma cases has allowed us to minimise and manage inadvertent skin contact, guide periocular injections and leakage from such injections and document conjunctival contact after periocular injection in addition to demonstrating the drug in the vitreous after intravitreal injection. The technique is safe, inexpensive and easy to perform.
AuthorsJasmine H Francis, Brian P Marr, Paula Schaiquevich, Michael G Kellick, David H Abramson
JournalThe British journal of ophthalmology (Br J Ophthalmol) Vol. 99 Issue 10 Pg. 1320-2 (Oct 2015) ISSN: 1468-2079 [Electronic] England
PMID25926516 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
CopyrightPublished by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Chemical References
  • Topoisomerase I Inhibitors
  • Topotecan
  • Fluorescein Angiography (methods)
  • Fundus Oculi
  • Humans
  • Intravitreal Injections
  • Retinal Neoplasms (diagnosis, drug therapy)
  • Retinoblastoma (diagnosis, drug therapy)
  • Topoisomerase I Inhibitors (administration & dosage)
  • Topotecan (administration & dosage)
  • Vitreous Body (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: